5MJC BCU 24: Efficacy of Administering Preoperative Hydroxyprogesterone in Women with Operable Breast CancerEfficacy of Administering Preoperative Hydroxyprogesterone in Women with Operable Breast Cancer Slides from a presentation at SABCS 2009 and transcribed comments from a recent interview with George W Sledge Jr, MD (2/15/10)Dr Sledge is Professor of Medicine and Pathology at the Indiana University School of Medicine and Co-Director of the IUSCC Breast Cancer Research Program at Indiana University Simon Cancer Center in Indianapolis, Indiana. Presentation discussed in this issue: Badwe RA et al. Single injection depot progesterone prior to surgery in women with operable breast cancer: A randomized controlled trial. San Antonio Breast Cancer Symposium 2009;Abstract 72. Go to previous Journal Club Go to next Journal Club
|